USA: Syngenta seeks approval for GM rice to help kidney patients
US agrochemicals company Syngenta is seeking regulatory approval for a genetically modified rice strain it says will improve the diet of patients undergoing kidney dialysis. The rice strain has been engineered to remove a protein which triggers allergic reactions. It has been designed for the Asian market, where dialysis patients cannot eat the local staple of rice because they suffer intolerance to its high protein content.
Get full access to all content, just $1 for 30 days
A Message From The Editor
just-food gives you the widest food market coverage.
Paid just-food members have unlimited access to all our exclusive content - including 16 years of archives.
It’s our best ever membership offer – just for you.
Dean Best, editor of just-food
- Unilever 2016 investor day - the top takeaways
- The key questions for digital strategists in 2017
- Wessanen's move for Spain's Biogran - analysis
- Have food promotions reached tipping point?
- Burger King, Jollibee: foodservice focus, Nov 2016
- General Mills jobs to go in business revamp
- Verlinvest, China Resources invest in Oatly
- B&G acquires pasta sauce group Victoria Fine Foods
- Japan's Nagatanien buys Chaucer Food Group
- Tyson sets up US$150m investment fund